Botulinum toxin type A inhibits rat pyloric myoelectrical activity and substance P release in vivo

Author： Hou Yi-Ping Zhang Yong-Ping Song Yan-Feng Zhu Chun-Min Wang Yin-Chun Xie Gui-Lin

ISSN： 1205-7541

Source： Canadian Journal of Physiology and Pharmacology, Vol.85, Iss.2, 2007-02, pp. : 209-214

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pyloric injection of botulinum toxin improves symptoms in patients with diabetic gastroparesis

Inpharma, Vol. 1, Iss. 1349, 2002-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Botulinum toxin type A for the treatment of migraine

By Aurora Sheena

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 8, 2006-06 ,pp. : 1085-1095

Informa Healthcare

Access to resources Recommend Favorite

Botulinum Toxin Type A for Facial Rejuvenation

By LOWE NICHOLAS J.

Dermatologic Surgery, Vol. 24, Iss. 11, 1998-11 ,pp. : 1216-1218

Elsevier

Access to resources Recommend Favorite

Substance P-(1-7) and substance P-(5-11) locally modulate dopamine release in rat striatum

By Saima K. Brooks N. Whelpton R. Michael-Titus A.T.

European Journal of Pharmacology, Vol. 282, Iss. 1, 1995-08 ,pp. : 229-233

Elsevier

Access to resources Recommend Favorite

Dynorphin-(1-8) inhibits the release of substance P-like immunoreactivity in the spinal cord of rats following a noxious mechanical stimulus

By Zachariou V. Goldstein B.D.

European Journal of Pharmacology, Vol. 323, Iss. 2, 1997-04 ,pp. : 159-165

Elsevier

Access to resources Recommend Favorite